Application 065033

Type
ANDA
Sponsor
TEVA PHARMS USA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BLEOMYCIN SULFATEBLEOMYCIN SULFATEINJECTABLE;INJECTIONEQ 15 UNITS BASE/VIALNoNo
002BLEOMYCIN SULFATEBLEOMYCIN SULFATEINJECTABLE;INJECTIONEQ 30 UNITS BASE/VIALNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A065033-001BLEOMYCIN SULFATEBLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27
A065033-002BLEOMYCIN SULFATEBLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27caaa826d4ba7…
2026-08-18 06:07:402026-07A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-2731067a03dcf5…
2025-08-23 18:47 UTC2025-08A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-276a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-2703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-2703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-272680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-272680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-275bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-275bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27d06236e962d9…
2024-10-29 15:01 UTC2024-10A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-2779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-2779d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-27301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-271e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-271e350fbaab3a…
2024-05-31 18:47 UTC2024-05A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-278072bd15b7f6…
2024-05-31 18:47 UTC2024-05A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTION2000-06-278072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTIONAP2000-06-275c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTIONAP2000-06-275c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTIONAP2000-06-275d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTIONAP2000-06-275d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTIONAP2000-06-274b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTIONAP2000-06-274b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTIONAP2000-06-2774a2ff9319b5…
2019-12-13 00:20 UTC2019-12A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTIONAP2000-06-2774a2ff9319b5…
2022-03-09 01:35 UTC2022-03A065033-001BLEOMYCIN SULFATEEQ 15 UNITS BASE/VIALINJECTABLE / INJECTIONAP2000-06-27bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A065033-002BLEOMYCIN SULFATEEQ 30 UNITS BASE/VIALINJECTABLE / INJECTIONAP2000-06-27bb7c543d1eb4…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 48 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065033-001AP15c6f7cd8ea54…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A065033-002AP15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A065033-001AP15d02ea3f76ae…
2022-04-08 23:34 UTC2022-04A065033-002AP15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A065033-001AP14b0b4de00fa7…
2022-04-04 05:41 UTC2022-04A065033-002AP14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A065033-001AP174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A065033-002AP174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A065033-001AP1bb7c543d1eb4…
2022-03-09 01:35 UTC2022-03A065033-002AP1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A065033-001AP1782e0a99824c…
2021-12-28 21:50 UTC2021-12A065033-002AP1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A065033-001AP187673890dc5c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A065033-002AP187673890dc5c…
2021-03-12 10:30 UTC2021-03A065033-001AP15aa47cf7b7d7…
2021-03-12 10:30 UTC2021-03A065033-002AP15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A065033-001AP18869cabd3fbd…
2020-12-22 03:56 UTC2020-12A065033-002AP18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A065033-001AP1c0c555d07b60…
2020-11-12 02:37 UTC2020-11A065033-002AP1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A065033-001AP13f01610625f2…
2019-12-14 00:12 UTC2019-12A065033-002AP13f01610625f2…
2019-09-15 20:21 UTC2019-09A065033-001AP1b00525d2431f…
2019-09-15 20:21 UTC2019-09A065033-002AP1b00525d2431f…
2019-07-19 19:46 UTC2019-07A065033-001AP1ea99ee380514…
2019-07-19 19:46 UTC2019-07A065033-002AP1ea99ee380514…
2023-12-20 04:57 UTC2023-12A065033-001AP1ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12A065033-002AP1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A065033-001AP1a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A065033-002AP1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A065033-001AP19b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A065033-002AP19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A065033-001AP1a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A065033-002AP1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A065033-001AP13f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A065033-002AP13f0d92c62455…
2023-05-13 08:27 UTC2023-05A065033-001AP1053a50430f4f…
2023-05-13 08:27 UTC2023-05A065033-002AP1053a50430f4f…
2023-01-26 05:58 UTC2023-01A065033-001AP13bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01A065033-002AP13bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BleomycinBLEOMYCIN SULFATEMeitheal Pharmaceuticals Inc.640602f9-a7df-46f0-a9b1-19c471008bee2026-04-17Boxed warning, Warnings, Adverse reactionsName fallback
generic name: BLEOMYCIN SULFATE
BleomycinBLEOMYCIN SULFATEFresenius Kabi USA, LLCb5806c40-12ce-48e3-8abd-9f8997ef44282024-10-10Boxed warning, Warnings, Adverse reactionsName fallback
generic name: BLEOMYCIN SULFATE

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 4 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0703-3154BleomycinBleomycinTeva Parenteral Medicines, Inc.ANDACurrent
0703-3154BleomycinBleomycinTeva Parenteral Medicines, Inc.ANDACurrent
0703-3155BleomycinBleomycinTeva Parenteral Medicines, Inc.ANDACurrent
0703-3155BleomycinBleomycinTeva Parenteral Medicines, Inc.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
8375ORIG2000-06-27